Reproductive Biology Associates Announces Launch of its R-Baby-Assurance Program

Tuesday, May 14, 2019 General News
Email Print This Page Comment bookmark
Font : A-A+

Program provides financial guarantee for eligible IVF patients.

ATLANTA, May 14, 2019 /PRNewswire-PRWeb/ -- Reproductive Biology Associates (RBA), part of the Prelude Fertility (Prelude)

network and the longest, continuously-operating and full-service private fertility treatment center in the United States, announces today the launch of its R-Baby-Assurance program.

This financial guarantee program gives eligible patients who are seeking in vitro fertilization (IVF) services the opportunity to pay a flat fee with the guarantee that they will take a baby home, or they are provided a full refund. The program fee costs start at $19,000 and includes seven fresh IVF cycles and unlimited subsequent frozen embryo transfers. It also includes preimplantation genetic testing for chromosomal aneuploidy, also known as PGT-A without additional charges. This test identifies embryos with the correct number of chromosomes to improve the chances of a successful pregnancy. The cost of the program does not include IVF medications.

For patients who do not have the luxury of insurance coverage for fertility services, the financial aspect associated with such treatments is often a determining factor as to how far they can go in their quest to have a baby. The new R-Baby-Assurance program gives RBA patients more financial options and more chances at conceiving a baby, in turn alleviating some of the stress that can be part of this process.

Patients eligible for the R-Baby-Assurance program include females under the age of 39 at the start of the program who wish to undergo IVF with their own eggs to obtain a pregnancy, whether for their own use with a male partner, female partner or a single female using donor sperm. Additionally, patients must meet certain medical criteria, which are reviewed by RBA clinical leaders. Patients who require the use of donor eggs can apply for RBA's Frozen Egg Advantage (FEA), which also provides a live birth guarantee.

RBA has six locations throughout the Atlanta-metro area, including Piedmont, Cumming, Fayetteville, Lawrenceville and Marietta. Its newest satellite location on the campus of Piedmont Atlanta Hospital is the only reproductive endocrinology practice on the Piedmont Atlanta hospital campus. The 2,235 square-foot, state-of-the-art facility offers a full range of comprehensive diagnostic and treatment services for women and men, including consultations, ultrasounds, bloodwork, as well as semen analysis, saline infusion sonohysterograms and OB checks.

Since its inception in 1983, RBA has remained steadfast in its commitment to the development of revolutionary technologies and techniques to enhance pregnancy outcomes. Its physicians boast more than 200 years of cumulative experience in the diagnosis and treatment of infertility and have achieved in excess of 30,000 babies. RBA's specialized treatment plans combine compassionate patient care with state-of-the-art technology, much of which its physicians pioneered. For more information about RBA and the R-Baby-Assurance program, please visit

About Reproductive Biology Associates Founded in 1983 and based in Atlanta, RBA is the longest continuously operating full-service private fertility treatment center in the United States and is led by reproductive endocrinologists Daniel B. Shapiro, MD, Medical Director; Andrew A. Toledo, MD, CEO; Jessica R. Rubin, MD; Scott M. Slayden, MD; Robert J. Straub, MD; urologist Michael A. Witt, MD and Zsolt Peter Nagy, PhD, who specializes in embryology. Since its establishment, the center's mission has focused on the development, improvement, and application of clinical and applied sciences to improve fertility care, with its RBA team being responsible for several notable firsts in reproductive medicine.

In 2016, RBA joined forces with Lee Equity Partners, serial entrepreneur Martín Varsavsky, and MyEggBank North America to establish Prelude, a comprehensive fertility company that is now the fastest growing network of fertility centers in the United States (Prelude Network). Prelude helps patients achieve their best possible pregnancy outcomes through access to top-tier centers, including RBA, and more than 30 internationally recognized reproductive endocrinologists, placing emphasis on the best clinical protocols and scientific advancements and sharing these best practices across its network.

About Prelude Fertility Prelude is a comprehensive fertility company focused on providing people with the best options for meeting their family-building goals. Using a proactive approach to fertility care, Prelude works to improve people's chances of having healthy babies when they are ready. Founded in 2016 by serial entrepreneur Martín Varsavsky, Lee Equity Partners, Reproductive Biology Associates, and MyEggBank, the company was established to give men and women more reproductive choices and greater control over their biological clocks. By coupling earlier decision-making with the latest reproductive science and technology, Prelude can increase the probability of having a healthy baby and decrease the chances of requiring infertility therapy later in life.

MEDIA CONTACT: Mia Humphreys Krupp Kommunications MHumphreys(at)kruppnyc(at)com


SOURCE Reproductive Biology Associates

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store